Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection. Issue 1 (3rd September 2020)

• Record Type: Journal Article
• Authors: Chung, Yousun; Kong, Jung Hee; Hu, Youmi; Lee, Se‐Na; Shim, Hyoeun; Eom, Hyeon‐Seok; Kong, Sun‐Young
• Is Part Of: Journal of clinical apheresis. Volume 36:Issue 1(2021)
• Page Start: 28
• Page End: 33
• Publication Date: 2020-09-03
• Subjects: apheresis -- cell separator -- collection -- peripheral blood stem cell; Hemapheresis -- Periodicals; Blood -- Transfusion -- Periodicals; Blood -- Transfusion, Autologous -- Periodicals; Cell separation -- Periodicals; Leukapheresis -- Periodicals; Plasmapheresis -- Periodicals; 615.39
• DOI: 10.1002/jca.21835
• Languages: English
• ISSNs: 0733-2459

Abstract

Abstract: Introduction: Autologous peripheral blood stem cell (PBSC) transplantation has become a standard treatment option for many oncology patients. The aim of this study was to evaluate the performance of two cell separators, Spectra Optia (Terumo BCT, Japan) and Amicus (Fresenius‐Kabi) for autologous PBSC collection. Methods: We retrospectively evaluated 56 apheresis by Spectra Optia with Continuous Mononuclear Cell Collection (cMNC) from 20 patients, and 50 apheresis by Amicus from 27 patients between December 2018 and December 2019. CD34+ collection efficiency (CE2) and platelet (PLT) loss were evaluated. Results: There was no significant difference in CD34+ CE2 between Spectra Optia with cMNC (median, 28.8%) and Amicus (median, 33.1%; P = 0.537). PLT loss was significantly lower in Amicus (median, 28.6%) than in Spectra Optia with cMNC (median, 37.8%; P = 0.009). Conclusion: CD34+ CE2 was comparable between Spectra Optia and Amicus, and PLT loss was significantly lower in Amicus. To the best of our knowledge, this is the first report comparing autologous PBSC collection of the Spectra Optia and Amicus. These results may provide general guidance with regard to device selection to apheresis clinics that use both separators for optimal outcomes depending on each patient's characteristics.